Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells

Experimental Cell Research

Volumn 249, Issue 2, 1999, Pages 422-428

  Chen, Fei ^a   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLIN DEPENDENT KINASE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033563703     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4522     Document Type: Article

References (30)

1. 3 precedes the G1/G0 phase cell cycle block. Cell Prolif. 27:1994;643-654.
2. Studzinski G. P., Rathod B., Wang Q. M., Rao J., Zhang F. Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants. Exp. Cell Res. 323:1997;376-387.
3. Bar-Shavit Z., Kahn A. J., Stone K. R., Trial J., Hilliard T., Reitsma P. H., Teitelbaum S. L. Reversibility of vitamin D-induced human leukemia cell-line maturation. Endocrinology. 118:1986;679-686.
4. Brelvi Z. S., Studzinski G. P. Coordinate expression of c-myc, c-myb and histone H4 genes in reversibly differentiating HL60 cells. J. Cell Physiol. 131:1987;43-49.
5. 3. Cell Prolif. 27:1994;37-46.
6. 3 in HL60 cells. Cancer Res. 56:1996;264-267.
7. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Gene Dev. 10:1996;142-153.
8. 3-treated HL60 cells. Cancer Res. 57:1997;2851-2855.
9. 3. Exp. Cell Res. 224:1996;312-322.
10. 3 display increased CDK2 and CDK6 activity and shortened G1 phase. Oncogene. 16:1998;2729-2737.
11. Wright S. D., Ramos R. A., Tobias S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
12. 3. J. Immunol. 153:1994;3276-3784.
13. 3 induces differentiation of HL60 cells with minimal effects on the cellular calcium homeostasis. J. Cell. Biochem. 63:1996;500-512.
14. Rovera G., O'Brien T. G., Diamond L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science. 204:1979;868-870.
15. Reichman T. W., Albanell J., Wang X., Moore M. A. S. Down-regulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J. Cell. Biochem. 67:1997;13-23.
16. Griffin J. D., Ritz J., Nadler L. M., Schlossman S. F. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J. Clin. Invest. 68:1981;932-941.
17. Lew J., Wang J. Neuronal cdc2-like kinase. Trends Biochem. Sci. 20:1995;33-36.
18. Tsai L. H., Takahashi T., Caviness V. S. Jr., Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development. 119:1993;1029-1040.
19. Guo-Zai Y., Ziff E. B. NGF regulates the PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1. J. Neurosci. 15:1995;6200-6212.
20. Halevy O., Novitch B. G., Spicer D. B., Skapek S. X., Rhee J., Hannon G. J., Beach D., Lassar A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
21. Meyerson M., Enders G. H., Wu C. L., Su L. K., Gorka C., Nelson C., Harlow E., Tsai L. H. A family of human cdc-related protein kinases. EMBO J. 11:1992;2909-2917.
22. Nikolic M., Dudek H., Kwon Y. T., Ramos Y. F. M., Tsai L. H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10:1996;816-825.
23. Lazaro J. B., Kitzmann M., Poul M. A., Vandromme M., Lamb N. J., Fernandez A. Cyclin-dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110:1997;1251-1260.
24. Philpott A., Porro E. B., Kirschner M. W., Tsai L. H. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11:1997;1409-1421.
25. Gao C. Y., Zakeri Z., Zhu Y., He H. Y., Zelenka P. S. Expression of cdk5, p35, and cdk5-associated kinase activity in the developing rat lens. Dev. Genet. 20:1997;267-275.
26. Li Z., Hromchak R., Bloch A. Differential expression of proteins regulating cell cycle progression in growth vs differentiation. Biochim. Biophys. Acta. 1356:1997;149-159.
27. Tsai L. H., Delalle I., Caviness V. S Jr., Chae T., Harlow E. p35 is a neural-specific regulatory subunit of cylin-dependent kinase 5. Nature. 29:1994;419-423.
28. Tang X. M., Strocchi P., Cambi F. Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J. Cell. Biochem. 68:1998;128-137.
29. 3 induces differentiation of human promyelocytic leukemia cells (HL60) into monocyte-macrophages, but not into granulocytes. Biochem. Biophys. Res. Commun. 117:1983;86-92.
30. Coffman F. D., Studzinski G. P. Differentiation-related mechanisms which suppress DNA replication. Exp. Cell Res. 248:1999;58-73.